Class 4 Caution in Use
Argenx BV have informed MHRA that the Patient Information Leaflet (PIL) in the affected packs incorrectly contains reference to two subcutaneous injection sites. Only subcutaneous injection to the abdomen is permitted.
MHRA Drug alert date: 19th December 2024
Pip code | Product description | Supplier | Batch Numbers |
ALLIANCE DO NOT STOCK | Vyvgart 1000 mg solution for injection | Argenx BV |
P99834CE P99834CJ P99834CK P99842CH
|
This is a caution in use only we are not accepting stock returns
Further Information
For medical information enquiries please contact ukmedinfo@argenx.com or +44 (0)20 4532 4016.
For stock control enquiries please contact rpi@argenx.com or +44 (0)7801 748936.